HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

5th Edition of International Conference on

Neurology and Neurological Disorders

June 15-16, 2022 | Rome, Italy

Neurology 2022

Lori A Gray, Speaker at
Oral Presentation
Lori A Gray, Western Michigan University, United States

Decades of research suggest that Mindfulness-Based Stress Reduction (MBSR) training supports a greater capacity to live with chronic medical conditions and contributes to lowering stress levels. This paper introduces a model for a Mindfulness-Based Recovery from Stroke (MBRfS) fo [....] » Read More

Calixto Machado, Speaker at
Oral Presentation
Calixto Machado, Institute of Neurology and Neurosurgery, Cuba

In this paper, I reviewed the case of Jahi McMath who was diagnosed as being in brain death (BD). Nonetheless, ancillary tests, performed 9 months after initial brain insult, showed conservation of intracranial structures, EEG activity, and autonomic reactivity to “Mother T [....] » Read More

Karisa B. Parkington, Speaker at
Oral Presentation
Karisa B. Parkington, Independent Researcher, Canada

Rationale: The ability to recognize faces and appropriately engage in eye contact are essential building blocks for efficient social communication. It is well established that neurotypical adults demonstrate an attentional bias for the eye region and tend to have relatively stron [....] » Read More

Karisa B. Parkington, Speaker at
Oral Presentation
Karisa B. Parkington, Independent Researcher, Canada

Rationale: Modern advances in technology and medicine provide promising avenues for the future of neurorehabilitation and psychotherapy. The advent of telemedicine and home-based solutions for health monitoring and/or treatment have made it possible for patients to have increased [....] » Read More

Sabine J. Bischoff, Speaker at
Oral Presentation (In-Person)
Sabine J. Bischoff, Jena University Hospital, Animal Welfare Unit, Germany

Preclinical studies are an important step on the way to new knowledge in the fields of neurology. Animal experiments are often used to validate newly developed drugs or to gain more knowledge about neurologic disorders. The use of laboratory animals is indispensable in this field [....] » Read More

Ken Ware, Speaker at 2022
Keynote Presentation (In-Person)
Ken Ware, Founder of Neurotricional Sciences and NeuroPhysics Therapy, Australia

There is an ever-increasing number of people around the world who reportedly suffer from one or more of the psychophysical conditions Fibromyalgia, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME), Postural orthostatic tachycardia syndrome (POTS). In the USA there are pres [....] » Read More

W S El Masri, Speaker at
Keynote Presentation (In-Person)
W S El Masri, Keele University, United Kingdom

Prior to the 2nd world war and for thousands of years TSCI challenged, frustrated and defeated the medical profession and the majority of patients died from a range of complications within two years of injury. During the 2nd world war Ludwig Guttmann (Neurosurgeon) in the UK d [....] » Read More

Raafat Mandour, Speaker at
Oral Presentation
Raafat Mandour, Mansoura University, Egypt

Background; Seizures often occur in substance abusers. The aim of the present work; is to study the etiology of non-response to antiepileptic drugs by estimating their serum levels and screening of drugs and substance abuse in patients with resistant epilepsy. Materials &am [....] » Read More

Pavlo V Osypenko, Speaker at
Oral Presentation
Pavlo V Osypenko, Medica Clinic Dobrobut, Ukraine

On the basis analysis of in vivo 1H MRS data we propose markers for the characteristics of the local metabolic state of the brain in patients with PD and different level of CI.  Three groups of PD-patients with various cognitive statuses are studied by MRI and 1H MRS with [....] » Read More

Nisha V Kimmatkar Wandile, Speaker at
Oral Presentation
Nisha V Kimmatkar Wandile, RCOEM College, India

The aim of this research study is to analyze emotional brain to detect emotional state by processing electroencephalography (EEG) signals and test effect of meditation music therapy to stabilize mental state. This study is useful to identify 12 subtle emotions angry (annoying, an [....] » Read More

Shinyi Chloe Chiou, Speaker at
Oral Presentation
Shinyi Chloe Chiou, University of Birmingham, United Kingdom

Abstract: Short Description of what will be discussed during the presentation Objectives: Many people living with spinal cord injury (SCI) exhibit reduced trunk control which can severely compromise the use of upper and lower extremities, hindering functional recovery. Current [....] » Read More

Manuela Marcoli, Speaker at
Oral Presentation (Virtual)
Manuela Marcoli, University of Genova, Italy

It is increasingly recognized that neurons and astrocytes are co-actors in the communication in central nervous system (CNS). Central to the view of astrocytes as active contributors in  brain signaling are the astrocytic receptors that respond to neurotransmitters and the [....] » Read More

Mikhail Reshetnikov, Speaker at Neurology Conferences
Oral Presentation (Virtual)
Mikhail Reshetnikov, East European Institute of Psychoanalysis (University), Russian Federation

For 2000 years, scientists searched for material foundations of the psyche, which proves to be non-material, thus this paradigm should be changed.   It has been proved that: 1) for 2000 years, most scientists mistook the concepts: while speaking about research and therapy [....] » Read More

Kenneth B Storey, Speaker at
Keynote Presentation (In-Person)
Kenneth B Storey, Carleton University, Canada

The human brain operates in a protected environment of constant temperature and uninterrupted resources of oxygen and nutrients. However, many other vertebrates show amazing plasticity of their brain function. Their brains function with greater flexibility and provide import [....] » Read More

Sergey Suchkov, Speaker at
Keynote Presentation (In-Person)
Sergey Suchkov, Moscow State University of Food Industry (MGUPP), Russian Federation

Catalytic Abs (catAbs) are multivalent immunoglobulins (Igs) with a capacity to hydrolyze the antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represent Abs to provide proteolytic effects. Abs against myelin basic protein/MBP with proteolytic activity ex [....] » Read More